469PD - Phase III trial of 24 weeks vs. 48 weeks capecitabine adjuvant chemotherapy for patients with stage III colon cancer: Final results of JFMC37-0801
| Autor: | Yamaguchi, S., Kunieda, K., Sato, T., Naramoto, Y., Kobayashi, M., Ogata, Y., Furuhata, T., Takii, Y., Kusunoki, M., Maehara, Y., Koda, K., Okuno, K., Ohno, M., Mishima, H., Sadahiro, S., Hamada, C., Sakamoto, J., Saji, S., Tomita, N. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi155-vi155 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|